CFO
TMDX icon

CVA Family Office’s Transmedics TMDX Stock Holding History

CVA Family Office’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$731 Buy
11
+1
+10% +$85 ﹤0.01% 1677
2026
Q1 		$994 Buy
+10
New +$1.3K ﹤0.01% 1651

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

CVA Family Office's TMDX Position: Q2 2026 in Review

CVA Family Office increased its Transmedics (TMDX) stake by 10% in Q2 2026, buying an estimated $85 and bringing the position to 11 shares worth $731. The position accounts for ﹤0.01% of the portfolio, ranked #1677.

CVA Family Office first reported a position in TMDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $994 in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • CVA Family Office held 11 shares of Transmedics worth $731 as of Q2 2026.
  • CVA Family Office bought 1 Transmedics share in Q2 2026, an estimated $85.
  • Transmedics made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1677 holding.
  • CVA Family Office first reported a position in Transmedics in Q1 2026 and has held it in 2 quarters since.
  • CVA Family Office's Transmedics position peaked at $994 in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.